We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
-9.26%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$406M
AUM Growth
-$87M
(-18%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-8.33%
Top 10 Holdings %
Top 10 Hldgs %
79.53%
Holding
86
New
3
Increased
3
Reduced
4
Closed
12
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
bluebird bio
BLUE
|
+$3.16M |
| 2 |
Liberty Live Group Series C
LLYVK
|
+$457K |
| 3 |
Liberty Live Group Series A
LLYVA
|
+$199K |
| 4 |
Curis
CRIS
|
+$161K |
| 5 |
LiqTech
LIQT
|
+$1.98K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CORS
Corsair Partnering Corporation
CORS
|
+$12.9M |
| 2 |
Thor Industries
THO
|
+$8.41M |
| 3 |
Ashland
ASH
|
+$3.53M |
| 4 |
2seventy bio
TSVT
|
+$2.58M |
| 5 |
DuPont de Nemours
DD
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.44% |
| 2 | Miscellaneous | 20.24% |
| 3 | Consumer Discretionary | 19% |
| 4 | Industrials | 15.46% |
| 5 | Materials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Bank of New York Mellon
BNY
$96.2B
| $85.3K | 0.02% |
2,000
| – | – |
2020 Q1
14 quarters
|
|
52
AbbVie
ABBV
$505B
| $76.8K | 0.02% |
515
| – | – |
2020 Q2
13 quarters
|
|
53
DELISTED
CompoSecure Inc Warrant
CMPOW
| $65K | 0.02% |
100,000
| – | – |
2022 Q1
6 quarters
|
|
54
Teradyne
TER
$52.6B
| $60.3K | 0.01% |
600
| – | – |
2020 Q2
13 quarters
|
|
55
Altria Group
MO
$123B
| $50.5K | 0.01% |
1,200
| – | – |
2020 Q2
13 quarters
|
|
56
Liberty Latin America Class A
LILA
$1.61B
| $32.8K | 0.01% |
5,913
| – | – |
2020 Q1
14 quarters
|
|
57
Lumentum
LITE
$76.8B
| $29.8K | 0.01% |
660
| – | – |
2020 Q2
13 quarters
|
|
58
AT&T
T
$161B
| $24.8K | 0.01% |
1,650
| – | – |
2020 Q2
13 quarters
|
|
59
ARK Blockchain & Fintech Innovation ETF
ARKF
$902M
| $23.2K | 0.01% |
1,200
| – | – |
2022 Q1
6 quarters
|
|
60
ARK Genomic Revolution ETF
ARKG
$2.08B
| $23K | 0.01% |
825
| – | – |
2022 Q1
6 quarters
|
|
61
X4 Pharmaceuticals
XFOR
$252M
| $19.5K | ﹤0.01% |
596
| – | – |
2019 Q4
15 quarters
|
|
62
SaverOne 2014 Ltd Warrant
SVREW
| $16.4K | ﹤0.01% |
121,000
| – | – |
2022 Q2
5 quarters
|
|
63
ARK Next Generation Technology ETF
ARKW
$2.22B
| $16.2K | ﹤0.01% |
300
| – | – |
2022 Q1
6 quarters
|
|
64
DELISTED
OppFi Inc Warrants
OPFI.WS
| $11.6K | ﹤0.01% |
250,000
| – | – |
2021 Q3
8 quarters
|
|
|
EQRX
65
DELISTED
EQRx, Inc. Common Stock
EQRX
| $11.1K | ﹤0.01% |
5,000
| – | – |
2022 Q1
6 quarters
|
|
|
EQRXW
66
DELISTED
EQRx, Inc. Warrant
EQRXW
| $8.02K | ﹤0.01% |
200,000
| – | – |
2021 Q2
9 quarters
|
|
67
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $5.03K | ﹤0.01% |
971
| – | – |
2021 Q1
10 quarters
|
|
68
DELISTED
Warner Bros
WBD
| $4.33K | ﹤0.01% |
399
| – | – |
2022 Q2
5 quarters
|
|
69
Alliance Entertainment Holding Corp Warrants
AENTW
| $3.8K | ﹤0.01% |
200,000
| – | – |
2023 Q2
1 quarter
|
|
|
SLGCW
70
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $3.09K | ﹤0.01% |
14,020
| – | – |
2021 Q2
9 quarters
|
|
71
Aviat Networks
AVNW
$250M
| $2.06K | ﹤0.01% |
66
| – | – |
2020 Q2
13 quarters
|
|
|
FAZEW
72
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
| $1.27K | ﹤0.01% |
75,000
| – | – |
2021 Q2
9 quarters
|
|
73
GeneDx Holdings
WGS
$2.15B
| $1.11K | ﹤0.01% |
304
+1
| +0.3% | +$5 |
2021 Q3
8 quarters
|
|
74
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $956 | ﹤0.01% |
517
-1
| -0.2% | -$4 |
2021 Q3
8 quarters
|
|
75
Federal Agricultural Mortgage
AGM
$2.23B
| – | – |
-15,080
| Closed | -$2.17M | – |
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q3 2023 Portfolio in Review
As of Q3 2023, Bleichroeder LP held 86 positions worth $406M, down 18% from $493M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Bleichroeder LP withdrew a net $33.8M in Q3 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was Corsair Partnering Corporation, an estimated $12.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
Against the trend, Bleichroeder LP opened a new position in bluebird bio worth $2.74M.
- Bleichroeder LP's largest Q3 2023 buy was bluebird bio: 45,000 shares worth $2.74M.
- Bleichroeder LP added most to Curis in Q3 2023, an estimated $161K increase.
- Bleichroeder LP's biggest Q3 2023 reduction was Liberty Media Corporation Series C Liberty SiriusXM Common Stock, cutting an estimated $390K.
- Bleichroeder LP fully exited Corsair Partnering Corporation in Q3 2023, selling an estimated $12.9M.
- Bleichroeder LP's ten largest holdings make up 80% of its $406M portfolio in Q3 2023.
- Bleichroeder LP opened 3 new positions and closed 12 in Q3 2023.
- Bleichroeder LP's portfolio value fell 18% quarter-over-quarter to $406M.
Based on Bleichroeder LP's 13F filing for Q3 2023, filed 9 Nov 2023.